OraSure Technologies Inc (OSUR) stock
OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3038% below fair value
$3.62+0.00 (0.00%)
Close on Nov 13, 2026Market cap $249.67MP/E –Yield –
OraSure Technologies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
OraSure Technologies's ebitda for the twelve months ending Sep 30, 2026 was -$41.57M. For fiscal 2025 it was -$61.78M. The highest annual figure on record is $53.62M in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$61.78M | – |
| FY2024 | Dec 31, 2024 | -$17.38M | -132.4% |
| FY2023 | Dec 31, 2023 | $53.62M | – |
| FY2022 | Dec 31, 2022 | -$6.85M | -558.4% |
| FY2021 | Dec 31, 2021 | $1.49M | -64.5% |
| FY2020 | Dec 31, 2020 | $4.21M | -83.8% |
| FY2019 | Dec 31, 2019 | $25.95M | -25.6% |
| FY2018 | Dec 31, 2018 | $34.88M | -24.7% |
| FY2017 | Dec 31, 2017 | $46.31M | +78.5% |
| FY2016 | Dec 31, 2016 | $25.95M | +87.2% |
| FY2015 | Dec 31, 2015 | $13.86M | +821.2% |
| FY2014 | Dec 31, 2014 | $1.51M | – |
| FY2013 | Dec 31, 2013 | -$5.61M | – |
| FY2012 | Dec 31, 2012 | -$9.02M | – |
| FY2011 | Dec 31, 2011 | -$4.51M | – |
| FY2010 | Dec 31, 2010 | -$342.00K | – |
| FY2009 | Dec 31, 2009 | -$5.74M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$10.76M | – |
| Q2 FY2026 | Jun 30, 2026 | $7.81M | – |
| Q1 FY2026 | Mar 31, 2026 | -$20.93M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.70M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.64M | – |
| Q2 FY2025 | Jun 30, 2025 | -$15.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.94M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.93M | -233.0% |
| Q3 FY2024 | Sep 30, 2024 | -$2.95M | -120.7% |
| Q2 FY2024 | Jun 30, 2024 | -$134.00K | -103.4% |
| Q1 FY2024 | Mar 31, 2024 | -$4.37M | -115.6% |
| Q4 FY2023 | Dec 31, 2023 | $7.46M | -59.7% |
| Q3 FY2023 | Sep 30, 2023 | $14.26M | +197.4% |
| Q2 FY2023 | Jun 30, 2023 | $3.89M | – |
| Q1 FY2023 | Mar 31, 2023 | $28.02M | – |
| Q4 FY2022 | Dec 31, 2022 | $18.54M | – |
| Q3 FY2022 | Sep 30, 2022 | $4.79M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.69M | -497.2% |
| Q1 FY2022 | Mar 31, 2022 | -$12.49M | -196.7% |
| Q4 FY2021 | Dec 31, 2021 | -$6.19M | -159.6% |
| Q3 FY2021 | Sep 30, 2021 | -$9.68M | -242.9% |
| Q2 FY2021 | Jun 30, 2021 | $4.45M | – |
| Q1 FY2021 | Mar 31, 2021 | $12.91M | – |
| Q4 FY2020 | Dec 31, 2020 | $10.39M | +76.4% |
| Q3 FY2020 | Sep 30, 2020 | $6.77M | -54.8% |
| Q2 FY2020 | Jun 30, 2020 | -$7.07M | -198.6% |
| Q1 FY2020 | Mar 31, 2020 | -$5.88M | – |
| Q4 FY2019 | Dec 31, 2019 | $5.89M | -55.9% |
| Q3 FY2019 | Sep 30, 2019 | $14.97M | +17.9% |
| Q2 FY2019 | Jun 30, 2019 | $7.17M | -3.6% |
| Q1 FY2019 | Mar 31, 2019 | -$2.09M | -252.2% |
| Q4 FY2018 | Dec 31, 2018 | $13.38M | +14.8% |
| Q3 FY2018 | Sep 30, 2018 | $12.70M | +40.8% |
| Q2 FY2018 | Jun 30, 2018 | $7.44M | -11.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.37M | -92.1% |
| Q4 FY2017 | Dec 31, 2017 | $11.65M | +35.3% |
| Q3 FY2017 | Sep 30, 2017 | $9.02M | – |
| Q2 FY2017 | Jun 30, 2017 | $8.36M | – |
| Q1 FY2017 | Mar 31, 2017 | $17.29M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.61M | – |
See a number that looks wrong?